Premium
Profound weight loss associated with reboxetine use in a 44‐year‐old woman
Author(s) -
Lu T. Y.T.,
Kupa A.,
Easterbrook G.,
Mangoni A. A.
Publication year - 2005
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/j.1365-2125.2005.02407.x
Subject(s) - reboxetine , weight loss , body mass index , medicine , body weight , obesity , reuptake inhibitor , receptor , serotonin
We report a case of significant weight loss experienced by a 44‐year‐old Caucasian woman treated with reboxetine. She was treated with this drug at 12 mg daily for a total duration of 11 months. During the corresponding period her body mass index (BMI) decreased from a baseline of 21.4 kg m −2 to a low of 16.8 kg m −2 . Withdrawal of the drug led to a full recovery of her BMI. The strongest evidence linking reboxetine to this woman's weight loss laid in the fact that the re‐introduction of the drug subsequently caused a similar negative impact in her BMI.